Novo Nordisk (NVO)
(Delayed Data from NYSE)
$48.19 USD
+1.12 (2.38%)
Updated Aug 1, 2025 03:59 PM ET
After-Market: $48.34 +0.15 (0.31%) 7:58 PM ET
4-Sell of 5 4
B Value C Growth B Momentum B VGM
Fundamental Charts
About Market Cap
As of the previous market close, Novo Nordisk A/S has a market cap of $210.17B, which represents its share price of $47.07 multiplied by its outstanding shares number of 4.47B. As a large-cap company, NVO's shareholders are generally exposed to less risk than shareholders of small and mid-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
NVO 48.19 +1.12(2.38%)
Will NVO be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for NVO based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for NVO
Buy, Sell or Hold Pfizer Stock? Key Tips Ahead of Q2 Earnings
Novo Nordisk (NVO) Registers a Bigger Fall Than the Market: Important Facts to Note
NVO: What are Zacks experts saying now?
Zacks Private Portfolio Services
NVO Stock Crashes 22% After 2025 View Cut: More Downside Ahead?
The Zacks Analyst Blog Highlights Tempus AI, NVIDIA, AstraZeneca and Novo Nordisk
Tempus AI or NVIDIA: Which is the Smarter Bet in AI-Backed Healthcare?
Other News for NVO
Trending stocks this week: Wall Street stumbles, Big Tech shines, and Figma steals the show
Notable analyst calls this week: Nike, Microsoft and Sarepta among top picks
Benzinga Bulls And Bears: Celestica, Carvana, Novo Nordisk — And Fed Holds Rates Despite Trump Pressure
Market Voices: Trump vs. Big Pharma, Swiss tariffs, tariff legality
Trump Administration Plan Signals Shift Toward Weight-Loss Drug Coverage For Medicare Patients